NovMetaPharma Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2010-11-04
- Employees
- 19
- Market Cap
- -
- Website
- http://www.novmeta.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Cyclo-ZOther: Placebo
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- NovMetaPharma Co., Ltd.
- Target Recruit Count
- 256
- Registration Number
- NCT03560271
- Locations
- 🇺🇸
Study Site 29, Anniston, Alabama, United States
🇺🇸Study Site 26, Birmingham, Alabama, United States
🇺🇸Study Site 27, Chula Vista, California, United States
A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus Type 2 in Obese
- Interventions
- Drug: Cyclo-ZDrug: Placebo
- First Posted Date
- 2016-05-27
- Last Posted Date
- 2018-07-12
- Lead Sponsor
- NovMetaPharma Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT02784275
News
No news found